We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26B
AUM Growth
+$684M
(+2.7%)
Cap. Flow
-$690M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
28.44%
Holding
2,103
New
155
Increased
550
Reduced
727
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$33.9M |
| 2 |
Allstate
ALL
|
+$28M |
| 3 |
Electronic Arts
EA
|
+$25.8M |
| 4 |
GE HealthCare
GEHC
|
+$24.7M |
| 5 |
Sherwin-Williams
SHW
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cintas
CTAS
|
+$46.2M |
| 2 |
NVIDIA
NVDA
|
+$41.1M |
| 3 |
Blackrock
BLK
|
+$39.1M |
| 4 |
Microsoft
MSFT
|
+$38.8M |
| 5 |
Apple
AAPL
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 13.2% |
| 3 | Healthcare | 11.07% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
1351
DELISTED
Axonics, Inc. Common Stock
AXNX
| $397K | ﹤0.01% |
5,700
+1,000
| +21% | +$68.6K |
|
1352
Newmark Group
NMRK
$2.73B
| $396K | ﹤0.01% |
25,500
| – | – |
|
1353
Quad
QUAD
$430M
| $395K | ﹤0.01% |
87,000
| – | – |
|
|
FLNA
1354
Filana Therapeutics
FLNA
$43M
| $394K | ﹤0.01% |
13,400
+1,500
| +13% | +$34.5K |
|
|
EQC
1355
DELISTED
Equity Commonwealth
EQC
| $394K | ﹤0.01% |
19,800
| – | – |
|
1356
Silicon Laboratories
SLAB
$7.15B
| $393K | ﹤0.01% |
3,400
+1,600
| +89% | +$179K |
|
|
TBI
1357
Trueblue
TBI
$234M
| $392K | ﹤0.01% |
49,700
| – | – |
|
1358
American Superconductor
AMSC
$1.48B
| $392K | ﹤0.01% |
+16,600
| New | +$383K |
|
1359
St. Joe Company
JOE
$3.57B
| $391K | ﹤0.01% |
6,700
| – | – |
|
1360
Costamare
CMRE
$1.9B
| $390K | ﹤0.01% |
+24,800
| New | +$357K |
|
|
LGF.A
1361
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $386K | ﹤0.01% |
49,300
| – | – |
|
1362
CNX Resources
CNX
$4.85B
| $384K | ﹤0.01% |
11,800
-4,800
| -29% | -$129K |
|
1363
Green Brick Partners
GRBK
$3.13B
| $384K | ﹤0.01% |
+4,600
| New | +$332K |
|
1364
Asbury Automotive
ABG
$4.19B
| $382K | ﹤0.01% |
1,600
-200
| -11% | -$47.1K |
|
1365
Verra Mobility
VRRM
$615M
| $381K | ﹤0.01% |
13,700
-700
| -5% | -$19.7K |
|
1366
Dyne Therapeutics
DYN
$4.04B
| $381K | ﹤0.01% |
10,600
| – | – |
|
1367
Alkermes
ALKS
$8.82B
| $381K | ﹤0.01% |
13,600
+1,000
| +8% | +$26.7K |
|
|
NAGE
1368
Niagen Bioscience
NAGE
$256M
| $380K | ﹤0.01% |
104,100
| – | – |
|
|
MPX
1369
DELISTED
Marine Products Corp
MPX
| $380K | ﹤0.01% |
39,200
| – | – |
|
1370
ArcBest
ARCB
$3.44B
| $380K | ﹤0.01% |
3,500
-500
| -13% | -$54.9K |
|
|
SUM
1371
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $379K | ﹤0.01% |
9,700
| – | – |
|
|
UDMY
1372
DELISTED
Udemy
UDMY
| $376K | ﹤0.01% |
50,600
-3,500
| -6% | -$28.2K |
|
1373
InnovAge Holding
INNV
$1.57B
| $375K | ﹤0.01% |
62,500
-3,700
| -6% | -$22K |
|
|
RYZ
1374
Ryerson Holding Corp
RYZ
$1.6B
| $374K | ﹤0.01% |
18,800
-4,400
| -19% | -$88.9K |
|
1375
Qualys
QLYS
$4.84B
| $373K | ﹤0.01% |
2,900
-3,100
| -52% | -$409K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q3 2024 Portfolio in Review
As of Q3 2024, STRS Ohio held 2,103 positions worth $26B, up 2.7% from $25.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
STRS Ohio's Q3 2024 filing shows 155 new, 550 increased, 727 reduced and 144 closed positions. Its largest new stake was Avery Dennison: 70,000 shares worth $15.5M. The largest sale was Cintas, an estimated $46.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q3 2024 buy was Avery Dennison: 70,000 shares worth $15.5M.
- STRS Ohio added most to IBM in Q3 2024, an estimated $33.9M increase.
- STRS Ohio's biggest Q3 2024 reduction was Cintas, cutting an estimated $46.2M.
- STRS Ohio fully exited West Pharmaceutical in Q3 2024, selling an estimated $32.1M.
- STRS Ohio's ten largest holdings make up 28% of its $26B portfolio in Q3 2024.
- STRS Ohio opened 155 new positions and closed 144 in Q3 2024.
- STRS Ohio's portfolio value rose 2.7% quarter-over-quarter to $26B.
Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.